Evidence map›Paper›PMID 39459912›Full record

ArticleViruses2024

Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses.

Pierre Gashema, Tumusime Musafiri, Felix Ndahimana, Hyppolyte Iradukunda, Eric Saramba, Stuart T Nyakatswau, Noel Gahamanyi, Patrick Gad Iradukunda, Ayman Ahmed, Tafadzwa Dzinamarira and 1 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pierre GashemaDepartment of Research, Repolicy Research Centre, Kigali P.O. Box 7584, Rwanda.ORCID 0000-0001-9348-0936
Tumusime MusafiriPartners in Health, Kigali P.O. Box 3432, Rwanda.ORCID 0000-0001-5863-2818
Felix NdahimanaLaboratory of Entomology, Wageningen University and Research, Droevendaalsesteeg 4, 6708 PB Wageningen, The Netherlands.ORCID 0000-0003-4008-6286
Hyppolyte IradukundaCollege of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 4285, Rwanda.
Eric SarambaDepartment of Research, Repolicy Research Centre, Kigali P.O. Box 7584, Rwanda.ORCID 0009-0003-3527-0262
Stuart T NyakatswauResearch and Development Department, Wastinnova Pvt Ltd., 5/39 Strachan St, Harare, Zimbabwe.
Noel GahamanyiRwanda Biomedical Centre, Kigali P.O. Box 7162, Rwanda.ORCID 0000-0001-7813-6440
Patrick Gad IradukundaDepartment of Research, Repolicy Research Centre, Kigali P.O. Box 7584, Rwanda.ORCID 0000-0002-0236-7776
Ayman AhmedFaculty of Science, University of Basel, Petersplatz 1, Basel P.O. Box 4001, Switzerland.ORCID 0000-0002-9516-9508
Tafadzwa DzinamariraICAP Columbia University, Lusaka, Zambia.ORCID 0000-0002-9929-5739
Claude Mambo MuvunyiRwanda Biomedical Centre, Kigali P.O. Box 7162, Rwanda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Africa Centers for Disease Control and Prevention declared mpox a Public Health Emergency of Continental Security (PHECS) in Africa. African public health systems have moved to mobilize a response against a backdrop of inherent significant challenges. With this commentary, we discuss how lessons from past public health emergencies, particularly COVID-19 and Ebola outbreaks, have prepared the region for improved disease surveillance, rapid response strategies, and effective public health communication and how these lessons can be applied to the mpox response, emphasizing the importance of strong healthcare infrastructure, effective data sharing, community engagement, targeted interventions, and robust contact tracing. Additionally, addressing misinformation and building public trust are crucial for controlling the spread of any disease. By leveraging these strategies, African countries can enhance their response to mpox. This includes improving diagnostic capabilities, strengthening cross-border collaborations, and prioritizing vaccination campaigns where needed. Ultimately, by applying the hard-earned lessons from the COVID-19 pandemic and Ebola outbreak, the East Africa region can better address the challenges posed by mpox and safeguard public health.

Indexed as

COVID-19Disease OutbreaksHemorrhagic Fever, EbolaPublic HealthSARS-CoV-2Africa, EasternHumansMpox, MonkeypoxPandemicsCOVID-19Ebola virusepidemicglobal health securitympox vaccinempox viruspandemicpoxvirus

Identifiers

PMID39459912
PMCPMC11512314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.